Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field

US10016381B2 · kind B2 · utility

Assignee

• Nogra Pharma Limited · IE

Inventors

• Giancarlo Naccari · Monza, IT
• Sergio Baroni · Rossera, IT

Key dates

• Filing date: Dec 13, 2016
• Grant date: Jul 10, 2018
• Expiry date: Dec 13, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C229/42
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to compounds comprising the general formula (I), in which R1 and R2, which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR3, —CH(OR3)COOH, in which R3 is selected from H, phenyl, benzyl, —CF3 or —CF2CF3, vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.